Search Results - "Giafis, N."

PCN95 Effect of Earlier Use of Ibrutinib on Healthcare Resource Utilization (HRU) and Costs Among Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) in the United States by Challagulla, S., Lee, P., Giafis, N., Manceur, A.M., Fakih, I., Emond, B., Iyengar, R.

Get full text

PCN144 IBRUTINIB TREATMENT IS ASSOCIATED WITH LOWER HEALTHCARE RESOURCE UTILIZATION AND TOTAL COST REDUCTION COMPARED TO CHEMOIMMUNOTHERAPY IN PATIENTS WITH MANTLE CELL LYMPHOMA by Iyengar, R., Malangone-Monaco, E., Sugg, C., Arthur, D., Sainski-Nguyen, A., Gelwicks, S., Giafis, N.

Get full text

PCN108 COMPARISON OF HEALTHCARE RESOURCE UTILIZATION AND COSTS FOR WALDENSTRÖM'S MACROGLOBULINEMIA (WM) PATIENTS TREATED WITH IBRUTINIB OR CHEMOIMMUNOTHERAPY by Iyengar, R., Malangone-Monaco, E., Sugg, C., Arango-Hisijara, I., Chen, Z., DeYoung, K., Chan, C., Giafis, N.

Get full text

PF383 PROGNOSTIC TESTING AND TREATMENT APPROACHES BASED ON REAL‐WORLD CLINICAL EXPERIENCE FROM AN INTERIM ANALYSIS OF THE INFORMCLL REGISTRY OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA by Mato, A.R., Barrientos, J.C., Brander, D., Pagel, J.M., Gutierrez, M., Kadish, K., Tomlinson, B., Ghosh, N., Giafis, N., Ipe, D., Upasani, S., Sundaram, M., Ferrante, L., Amaya‐Chanaga, C.I., Iyengar, R., Sharman, J.P.

“…Background: Given the availability of novel targeted agents and updated guidelines for treatment (tx) of chronic lymphocytic leukemia (CLL), molecular‐genetic…”
Get full text

Activation of Protein Kinase Cδ by All-trans-retinoic Acid by Kambhampati, Suman, Li, Yongzhong, Verma, Amit, Sassano, Antonella, Majchrzak, Beata, Deb, Dilip K., Parmar, Simrit, Giafis, Nick, Kalvakolanu, Dhananjaya V., Rahman, Arshad, Uddin, Shahab, Minucci, Saverio, Tallman, Martin S., Fish, Eleanor N., Platanias, Leonidas C.

“…All-trans-retinoic acid (RA) is a potent inhibitor of leukemia cell proliferation and induces differentiation of acute promyelocytic leukemia cells in vitro…”
Get full text

Activation of Protein Kinase C[delta] by All-trans-retinoic Acid by Kambhampati, S, Li, Y, Verma, A, Sassano, A, Majchrzak, B, Deb, D K, Parmar, S, Giafis, N, Kalvakolanu, D V, Rahman, A, Uddin, S, Minucci, S, Tallman, MS, Fish, EN, Platanias, L C

“…All-trans-retinoic acid (RA) is a potent inhibitor of leukemia cell proliferation and induces differentiation of acute promyelocytic leukemia cells in vitro…”
Get full text